Silbert

Cassava | Tomorrow - scheduled end of phase IIb | Jackpot?

Длинная
Silbert Обновлено   
NASDAQ:SAVA   Cassava Sciences, Inc.
Is SAVA about to blow up soon? The phase IIb will be most likely done by tomorrow whereby the analysis and evaluation of the results is scheduled for May. So there might be one last pullback before the stock will pulverize the last highs (in case the results are positive!). As a consequence of that I will look for good entries to ride the stock to at least 20$ per share :).
Комментарий:
Launch successful :). The NIH is funding another $2.5 million, which might be a good sign for positive phase 2b results.
Комментарий:
The results aren't published yet, but the expectations grow! The stock is rising sharply :)

Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.